Secukinumab: In psoriasis and beyond

被引：0

作者：

Bubna, Aditya K. ^{[1
]}

Viplav, Vinayak ^{[1
]}

机构：

[1] Katihar Med Coll, Dept Dermatol, Katihar 854106, Bihar, India

来源：

JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY | 2025年 / 22卷 / 01期

关键词：

hidradenitis suppurativa; off-label dermatologic indications; psoriasis; secukinumab; ORAL LICHEN-PLANUS; HIDRADENITIS SUPPURATIVA; PALMOPLANTAR PSORIASIS; PYODERMA-GANGRENOSUM; CONTROLLED-TRIAL; DOUBLE-BLIND; TH17; EFFICACY; THERAPY; SAFETY;

D O I：

10.4103/jewd.jewd_80_23

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Secukinumab is an IL-17A antagonist, approved by the FDA for the treatment of adult and pediatric (>= 6 years) psoriasis, psoriatic arthropathy, and hidradenitis suppurativa. Of late, secukinumab has been found to be beneficial in pityriasis rubra pilaris, pyoderma gangrenosum, lichen planus, and Beh & ccedil;et's disease. This review will throw light on secukinumab's utility in psoriasis, as well as other dermatologic conditions.

引用

页码：1 / 12

页数：12

共 50 条

[21] Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion [J].

Dragatin, Christian ;

Polus, Florine ;

Bodenlenz, Manfred ;

Calonder, Claudio ;

Aigner, Birgit ;

Tiffner, Katrin Irene ;

Mader, Julia Katharina ;

Ratzer, Maria ;

Woessner, Ralph ;

Pieber, Thomas Rudolf ;

Cheng, Yi ;

Loesche, Christian ;

Sinner, Frank ;

Bruin, Gerard .

EXPERIMENTAL DERMATOLOGY, 2016, 25 (02) :157-159

[22] Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study [J].

Blauvelt, Andrew ;

Pariser, David M. ;

Tyring, Stephen ;

Bagel, Jerry ;

Alexis, Andrew F. ;

Soung, Jennifer ;

Armstrong, April W. ;

Muscianisi, Elisa ;

Kianifard, Farid ;

Steadman, Jennifer ;

Sarkar, Rajendra Prasad ;

Garcet, Sandra ;

Krueger, James G. .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2023, 109 (01) :12-21

[23] Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective [J].

Igarashi, Atsuyuki ;

Igarashi, Ataru ;

Graham, Christopher N. ;

Gilloteau, Isabelle ;

Tani, Yumiko .

JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (01) :7-15

[24] Bimekizumab versus Secukinumab in Plaque Psoriasis [J].

Reich, Kristian ;

Warren, Richard B. ;

Lebwohl, Mark ;

Gooderham, Melinda ;

Strober, Bruce ;

Langley, Richard G. ;

Paul, Carle ;

De Cuyper, Dirk ;

Vanvoorden, Veerle ;

Madden, Cynthia ;

Cioffi, Christopher ;

Peterson, Luke ;

Blauvelt, Andrew .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) :142-152

[25] Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review [J].

Dauden, Esteban ;

Ortiz-Salvador, Jose Maria ;

Notario, Jaime ;

Puig, Lluis ;

Santos-Juanes, Jorge ;

Herrera-Acosta, Enrique ;

Gomez-Labrador, Lara ;

Ruiz-Villaverde, Ricardo .

JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)

[26] Ustekinumab: In Psoriasis and Beyond -A Derm atological Perspective [J].

Bubna, Aditya Kumar ;

Viplav, Vinayak .

JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2024, 15 (02) :105-121

[27] Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial [J].

Gottlieb, Alice ;

Sullivan, John ;

van Doorn, Martijn ;

Kubanov, Alexey ;

You, Ruquan ;

Parneix, Anne ;

Hugot, Sophie ;

Milutinovic, Marina .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) :70-80

[28] Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis [J].

Akdogan, Neslihan ;

Balan, Kerem ;

Armagan, Basak Yalici ;

Gulseren, Duygu ;

Dogan, Sibel .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (08) :755-762

[29] Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study [J].

Blauvelt, Andrew ;

Reich, Kristian ;

Tsai, Tsen-Fang ;

Tyring, Stephen ;

Vanaclocha, Francisco ;

Kingo, Kulli ;

Ziv, Michael ;

Pinter, Andreas ;

Vender, Ronald ;

Hugot, Sophie ;

You, Ruquan ;

Milutinovic, Marina ;

Thaci, Diamant .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) :60-+

[30] Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis [J].

Wong, Ian T. Y. ;

Shojania, Kam ;

Dutz, Jan ;

Tsao, Nicole W. .

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) :153-166

← 1 2 3 4 5 →